K. pneumoniae
Emery Haley, PhD, Scientific Writer
CHECK BACK SOON FOR OUR FULL BLOG ON THE IMPORTANCE OF KLEBSIELLA PNEUMONIAE
Subscribe to our emails and get notified as soon as new blogs are published.
1. BacDive | The Bacterial Diversity Metadatabase Available online: https://bacdive.dsmz.de/ (accessed on 11 February 2025).
2. Oelschlaeger, T.A.; Tall, B.D. Invasion of Cultured Human Epithelial Cells by Klebsiella Pneumoniae Isolated from the Urinary Tract. Infect. Immun. 1997, 65, 2950–2958, doi:10.1128/iai.65.7.2950-2958.1997.
3. Le, T.; Nang, S.C.; Zhao, J.; Yu, H.H.; Li, J.; Gill, J.J.; Liu, M.; Aslam, S. Therapeutic Potential of Intravenous Phage as Standalone Therapy for Recurrent Drug-Resistant Urinary Tract Infections. Antimicrob. Agents Chemother. 2023, 67, e00037-23, doi:10.1128/aac.00037-23.
4. Lin, W.H.; Kao, C.Y.; Yang, D.C.; Tseng, C.C.; Wu, A.B.; Teng, C.H.; Wang, M.C.; Wu, J.J. Clinical and Microbiological Characteristics of Klebsiella Pneumoniae from Community-Acquired Recurrent Urinary Tract Infections. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 1533–1539, doi:10.1007/s10096-014-2100-4.
5. CRISTEA, O.M.; AVRĂMESCU, C.S.; BĂLĂȘOIU, M.; POPESCU, F.D.; POPESCU, F.; AMZOIU, M.O. Urinary Tract Infection with Klebsiella Pneumoniae in Patients with Chronic Kidney Disease. Curr. Heal. Sci. J. 2017, 43, 137–148, doi:10.12865/chsj.43.02.06.
6. Zafar, S.; Hanif, S.; Akhtar, H.; Faryal, R. Emergence of Hypervirulent K. Pneumoniae Causing Complicated UTI in Kidney Stone Patients. Microb. Pathog. 2019, 135, 103647, doi:10.1016/j.micpath.2019.103647.
7. Parente, G.; Gargano, T.; Pavia, S.; Cordola, C.; Vastano, M.; Baccelli, F.; Gallotta, G.; Bruni, L.; Corvaglia, A.; Lima, M. Pyelonephritis in Pediatric Uropathic Patients: Differences from Community-Acquired Ones and Therapeutic Protocol Considerations. A 10-Year Single-Center Retrospective Study. Children 2021, 8, 436, doi:10.3390/children8060436.
8. Obaid, N.A.; Abuhussain, S.A.; Mulibari, K.K.; Alshanqiti, F.; Malibari, S.A.; Althobaiti, S.S.; Alansari, M.; Muneef, E.; Almatrafi, L.; Alqarzi, A.; et al. Antimicrobial-Resistant Pathogens Related to Catheter-Associated Urinary Tract Infections in Intensive Care Units: A Multi-Center Retrospective Study in the Western Region of Saudi Arabia. Clin. Epidemiology Glob. Heal. 2023, 21, 101291, doi:10.1016/j.cegh.2023.101291.
9. Kayaaslan, B.; Oktay, Z.; Hasanoglu, I.; Kalem, A.K.; Eser, F.; Ayhan, M.; Guner, R. Increasing Rates of Extended-Spectrum B-Lactamase-Producing Escherichia Coli and Klebsiella Pneumoniae in Uncomplicated and Complicated Acute Pyelonephritis and Evaluation of Empirical Treatments Based on Culture Results. Eur. J. Clin. Microbiol. Infect. Dis. 2022, 41, 421–430, doi:10.1007/s10096-021-04392-2.
10. D’Incau, S.; Atkinson, A.; Leitner, L.; Kronenberg, A.; Kessler, T.M.; Marschall, J. Bacterial Species and Antimicrobial Resistance Differ between Catheter and Non–Catheter-Associated Urinary Tract Infections: Data from a National Surveillance Network. Antimicrob. Steward. Healthc. Epidemiology : ASHE 2023, 3, e55, doi:10.1017/ash.2022.340.
11. Miller, W.R.; Arias, C.A. ESKAPE Pathogens: Antimicrobial Resistance, Epidemiology, Clinical Impact and Therapeutics. Nat. Rev. Microbiol. 2024, 22, 598–616, doi:10.1038/s41579-024-01054-w.
12. Joseph, L.; Merciecca, T.; Forestier, C.; Balestrino, D.; Miquel, S. From Klebsiella Pneumoniae Colonization to Dissemination: An Overview of Studies Implementing Murine Models. Microorganisms 2021, 9, 1282, doi:10.3390/microorganisms9061282.
13. Abell-King, C.; Pokhrel, A.; Rice, S.A.; Duggin, I.G.; Söderström, B. Multispecies Bacterial Invasion of Human Host Cells. Pathog. Dis. 2024, 82, ftae012, doi:10.1093/femspd/ftae012.
14. Gaston, J.R.; Johnson, A.O.; Bair, K.L.; White, A.N.; Armbruster, C.E. Polymicrobial Interactions in the Urinary Tract: Is the Enemy of My Enemy My Friend? Infect Immun 2021, 89, doi:10.1128/iai.00652-20.
15. Wang, D.; Haley, E.; Luke, N.; Mathur, M.; Festa, R.; Zhao, X.; Anderson, L.A.; Allison, J.L.; Stebbins, K.L.; Diaz, M.J.; et al. Emerging and Fastidious Uropathogens Were Detected by M-PCR with Similar Prevalence and Cell Density in Catheter and Midstream Voided Urine Indicating the Importance of These Microbes in Causing UTIs. Infect. Drug Resist. 2023, Volume 16, 7775–7795, doi:10.2147/idr.s429990.
16. Haley, E.; Luke, N.; Mathur, M.; Festa, R.A.; Wang, J.; Jiang, Y.; Anderson, L.A.; Baunoch, D. The Prevalence and Association of Different Uropathogens Detected by M-PCR with Infection-Associated Urine Biomarkers in Urinary Tract Infections. Res. Rep. Urol. 2024, 16, 19–29, doi:10.2147/rru.s443361.
17. Akhlaghpour, M.; Haley, E.; Parnell, L.; Luke, N.; Mathur, M.; Festa, R.A.; Percaccio, M.; Magallon, J.; Remedios-Chan, M.; Rosas, A.; et al. Urine Biomarkers Individually and as a Consensus Model Show High Sensitivity and Specificity for Detecting UTIs. BMC Infect Dis 2024, 24, 153, doi:10.1186/s12879-024-09044-2.
18. Parnell, L.K.D.; Luke, N.; Mathur, M.; Festa, R.A.; Haley, E.; Wang, J.; Jiang, Y.; Anderson, L.; Baunoch, D. Elevated UTI Biomarkers in Symptomatic Patients with Urine Microbial Densities of 10,000 CFU/ML Indicate a Lower Threshold for Diagnosing UTIs. MDPI 2023, 13, 1–15, doi:10.3390/diagnostics13162688.
19. Wu, Y.; Li, P.; Huang, Z.; Liu, J.; Yang, B.; Zhou, W.; Duan, F.; Wang, G.; Li, J. Four-Year Variation in Pathogen Distribution and Antimicrobial Susceptibility of Urosepsis: A Single-Center Retrospective Analysis. Ther. Adv. Infect. Dis. 2024, 11, 20499361241248056, doi:10.1177/20499361241248058.
20. Shahab, K.; Mufti, A.Z.; Iqbal, M.A.; Roghani, M.; Zeb, F.; Amin, U. Assessment of Microbial Diversity Pattern of Sensitivity and Antimicrobial Susceptibility in Patients Admitted with Urosepsis. Ann. PIMS-Shaheed Zulfiqar Ali Bhutto Méd. Univ. 2023, 19, 339–345, doi:10.48036/apims.v19i3.924.
Dr. Emery Haley is a scientific writing specialist with over ten years of experience in translational cell and molecular biology. As both a former laboratory scientist and an experienced science communicator, Dr. Haley is passionate about making complex research clear, approachable, and relevant. Their work has been published in over 10 papers and focuses on bridging the gap between the lab and real-world patient care to help drive better health outcomes.